Bioharvest sciences reports first quarter 2025 financial results

First quarter revenues grew 47% to $7.9 million, exceeding management guidance rehovot, israel--(newsfile corp. - may 15, 2025) - bioharvest sciences inc. (nasdaq: bhst) (fse: 8mv0) ("bioharvest" or the "company"), a company pioneering its patented botanical synthesis technology platform, today reported its financial and operational results for the first quarter ended march 31, 2025. first quarter & subsequent 2025 operational highlights all figures stated in this news release are in u.s. dollars unless stated otherwise.
BHST Ratings Summary
BHST Quant Ranking